Rasa Huseyin K, Erdemir Ayhan
General Surgery, Anadolu Medical Center Hospital, Kocaeli, TUR.
Cureus. 2023 Sep 14;15(9):e45209. doi: 10.7759/cureus.45209. eCollection 2023 Sep.
Evidence about the importance of sarcopenia in patients operated on for gastrointestinal cancers and that it may have both early and long-term impacts is expanding. In our study, we aimed to evaluate the impact of sarcopenia on the outcomes of the patients we operated on for left colon and rectum cancer.
We retrospectively evaluated the electronic records of 38 patients operated on for left colon and rectal cancer between 2010 and 2020, and demographic variables, clinical stages, laboratory tests, body mass index (BMI), psoas muscle index (PMI), pathological stages, and Dindo Clavien complication scores were interpreted. We also assigned our patients into two groups according to their preoperative PMI values. We compared the first group of 12 patients with preoperative sarcopenia with the second group of 26 patients without preoperative sarcopenia.
Of the 38 patients who underwent curative surgery for left colon and rectal cancer, 20 were female and 18 were male. The median age of the group was 59.9 years. The most common tumour localization was in the rectosigmoid region in 17 patients, and the tumour in 6 patients was in the left colon. Therapy had been initiated with neoadjuvant treatment in 19 patients. At the preoperative evaluation, sarcopenia was present in 12 patients. Thirty-four patients underwent robot-assisted surgery. Postoperative pathologies were reported as stage 3 in 15 patients. Complications were reported in 17 patients, and nine were minor (Dindo-Clavien score < 3), but in eight patients, they were moderate to severe (Dindo-Clavien score ≥ 3). When the first group, 12 patients with preoperative sarcopenia, and the second group, 26 patients without preoperative sarcopenia, were compared, the patients with sarcopenia were found to be older (p=0.001), and male patients were in the majority (p=0.017). The postoperative follow-up of 12 patients with preoperative sarcopenia revealed that 7 (58.8%) had complications. Complications were observed in 10 (38.4%) patients in the second group. When the two groups were compared, the risk of developing complications was significantly higher in the sarcopenia group (p=0.016). Only one patient in the first group had moderate to severe complications, but seven patients without sarcopenia had moderate to severe complications.
Our study revealed that many patients we have operated on for left colon and rectal cancer have preoperative sarcopenia for which we should care. The sarcopenia rate was higher in males and elderly patients, and the risk of overall postoperative complications increased significantly in patients with preoperative sarcopenia. In consequence, the results of our study provide evidence that preoperative sarcopenia status is an important parameter to determine the risk status of the patient, and patients with preoperative sarcopenia should be monitored more closely. Thus, we may be able to diagnose and intervene early in the complications.
关于肌肉减少症在接受胃肠道癌手术患者中的重要性及其可能产生早期和长期影响的证据正在不断增加。在我们的研究中,我们旨在评估肌肉减少症对接受左结肠癌和直肠癌手术患者预后的影响。
我们回顾性评估了2010年至2020年间38例接受左结肠癌和直肠癌手术患者的电子病历,并对人口统计学变量、临床分期、实验室检查、体重指数(BMI)、腰大肌指数(PMI)、病理分期和Dindo Clavien并发症评分进行了解读。我们还根据患者术前PMI值将其分为两组。我们将第一组12例术前存在肌肉减少症的患者与第二组26例术前无肌肉减少症的患者进行了比较。
在38例接受左结肠癌和直肠癌根治性手术的患者中,女性20例,男性18例。该组患者的中位年龄为59.9岁。最常见的肿瘤定位是17例患者的直肠乙状结肠区域,6例患者的肿瘤位于左结肠。19例患者以新辅助治疗开始治疗。在术前评估中,12例患者存在肌肉减少症。34例患者接受了机器人辅助手术。术后病理报告15例为3期。17例患者报告有并发症,9例为轻度(Dindo-Clavien评分<3),但8例患者为中度至重度(Dindo-Clavien评分≥3)。当比较第一组12例术前有肌肉减少症的患者和第二组26例术前无肌肉减少症的患者时,发现有肌肉减少症的患者年龄更大(p=0.001),且男性患者占多数(p=0.017)。对12例术前有肌肉减少症的患者进行术后随访发现,7例(58.8%)有并发症。第二组10例(38.4%)患者观察到有并发症。当两组进行比较时,肌肉减少症组发生并发症的风险显著更高(p=0.016)。第一组中只有1例患者有中度至重度并发症,但7例无肌肉减少症的患者有中度至重度并发症。
我们的研究表明,许多接受左结肠癌和直肠癌手术的患者术前存在肌肉减少症,对此我们应予以关注。男性和老年患者的肌肉减少症发生率更高,术前有肌肉减少症的患者术后总体并发症风险显著增加。因此,我们的研究结果提供了证据,表明术前肌肉减少症状态是确定患者风险状态的一个重要参数,术前有肌肉减少症的患者应更密切地监测。这样,我们或许能够早期诊断并干预并发症。